CURRENT MEDICATIONS OVERVIEW,,
MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST
"Ibuprofen",CYP2C9,"Minor – result should be considered as may affect medicationresponse"
"Citalopram",CYP2C19,Usual prescribing considerations apply
MEDICATIONS THAT DO NOT HAVE PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,,
cephalexin,,
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Anticoagulants,Acenocoumarol,"VKORC1CYP2C9","Significantly increasedacenocoumarol sensitivity",DPWG
"",Warfarin,"VKORC1CYP2C9","Significantly increased warfarinsensitivity",FDA3
Antiepileptics,Phenytoin,CYP2C9,Adverse effects,CPIC4
Statins,Simvastatin,"SLCO1B1CYP3A4",Adverse effects,CPIC5
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,Adverse effects,-
"Angiotensin receptorblockers",Irbesartan,CYP2C9,"Increased therapeutic and/oradverse effects",-
Antiarrhythmics,Flecainide,CYP2D6,Adverse effects,DPWG6
"",Propafenone,CYP2D6,Adverse effects,DPWG6
"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2",Altered response,-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2",Reduced / inadequate response,-
"",Venlafaxine,CYP2D6,Adverse effects,DPWG6
"Antidepressants -SSRIs",Paroxetine,CYP2D6,Adverse effects,CPIC2
"Antidepressants -tricyclicantidepressants",Desipramine,CYP2D6,Adverse effects,CPIC7
Nortriptyline,CYP2D6,Adverse effects,CPIC7,
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Antidiabetics,Gliclazide,"CYP2C9CYP2C19","Increased therapeutic and/oradverse effects",-
"",Glimepiride,CYP2C9,"Increased therapeutic and/oradverse effects",-
"",Glyburide,CYP2C9,"Increased therapeutic and/oradverse effects",-
Antiemetics,Ondansetron,CYP2D6,"Increased therapeutic and/oradverse effects",CPIC8
Antihistamines,Chlorpheniramine,CYP2D6,Adverse effects,-
"",Dexchlorpheniramine,CYP2D6,Adverse effects,-
Antipsychotics,Aripiprazole,CYP2D6,Adverse effects,-
"",Brexpiprazole,CYP2D6,Adverse effects,-
"",Clozapine,CYP1A2,Reduced / inadequate response,-
"",Haloperidol,CYP2D6,Adverse effects,-
"",Olanzapine,CYP1A2,Reduced / inadequate response,-
"",Pimozide,CYP2D6,Adverse effects,
"",Risperidone,CYP2D6,Adverse effects,DPWG6
"",Zuclopenthixol,CYP2D6,Adverse effects,DPWG6
Antitussives,Dextromethorphan,CYP2D6,Altered response,-
Beta blockers,Metoprolol,CYP2D6,Adverse effects,DPWG6
"",Propranolol,"CYP2D6CYP1A2",Altered response,-
Hypnotics,Melatonin,CYP1A2,Reduced / inadequate response,-
"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,Reduced / inadequate response,CPIC9
Miscellaneous,Eliglustat,CYP2D6,Adverse effects,TGA10
"",Naltrexone,OPRM1,"Associated with reducedresponse to naltrexone",
Neurological drugs,Tetrabenazine,CYP2D6,Adverse effects,FDA11
NSAIDs,Celecoxib,CYP2C9,"Increased therapeutic and/oradverse effects",-
"",Flurbiprofen,CYP2C9,Adverse effects,-
"",Ibuprofen,CYP2C9,Adverse effects,-
"",Meloxicam,CYP2C9,Adverse effects,-
"",Piroxicam,CYP2C9,Adverse effects,-
Opioid Analgesics,Morphine,OPRM1,"Associated with increasedtherapeutic and/or adverseeffects to morphine",-
"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,Reduced / inadequate response,-
"",Esomeprazole,CYP2C19,Reduced / inadequate response,-
"",Lansoprazole,CYP2C19,Reduced / inadequate response,-
"",Omeprazole,CYP2C19,Reduced / inadequate response,-
"",Pantoprazole,CYP2C19,Reduced / inadequate response,-
"",Rabeprazole,CYP2C19,Reduced / inadequate response,-
Statins,Atorvastatin,"SLCO1B1CYP3A4",Adverse effects,-
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Angiotensin receptorblockers",Losartan,CYP2C9,"No altered effect predicted bygenotype",-
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,"No altered effect predicted bygenotype",-
"",Fesoterodine,CYP2D6,"No altered effect predicted bygenotype",-
"",Tolterodine,CYP2D6,"No altered effect predicted bygenotype",-
Anticholinesterases,Donepezil,CYP2D6,"No altered effect predicted bygenotype",-
"",Galantamine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -other",Moclobemide,CYP2C19,"No altered effect predicted bygenotype",-
"",Vortioxetine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -SSRIs",Citalopram,CYP2C19,"No altered effect predicted bygenotype",CPIC2
"",Escitalopram,CYP2C19,"No altered effect predicted bygenotype",CPIC2
"",Fluoxetine,"CYP2D6CYP2C9","No altered effect predicted bygenotype",-
"",Fluvoxamine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",CPIC2
"",Sertraline,CYP2C19,"No altered effect predicted bygenotype",CPIC2
"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19","No altered effect predicted bygenotype",CPIC7
"",Clomipramine,"CYP2D6CYP2C19","No altered effect predicted bygenotype",CPIC7
"",Doxepin,"CYP2D6CYP2C19","No altered effect predicted bygenotype",CPIC7
"",Imipramine,"CYP2D6CYP2C19","No altered effect predicted bygenotype",CPIC7
Antiemetics,Metoclopramide,CYP2D6,"No altered effect predicted bygenotype",-
Antifungals - Azoles,Voriconazole,CYP2C19,"No altered effect predicted bygenotype",CPIC12
Antihistamines,Promethazine,CYP2D6,Adverse effects,-
Antiplatelet drugs,Clopidogrel,CYP2C19,"No altered effect predicted bygenotype",CPIC13
Antipsychotics,Chlorpromazine,CYP2D6,"No altered effect predicted bygenotype",-
"",Quetiapine,CYP3A4,"No altered effect predicted bygenotype",-
Benzodiazepines,Clobazam,CYP2C19,"No altered effect predicted bygenotype",-
"",Diazepam,CYP2C19,"No altered effect predicted bygenotype",-
Beta blockers,Carvedilol,CYP2D6,"No altered effect predicted bygenotype",-
"",Nebivolol,CYP2D6,"No altered effect predicted bygenotype",-
Calcineurin inhibitors,Tacrolimus,CYP3A5,"No altered effect predicted bygenotype",CPIC14
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Glaucoma - ocularpreparations",Timolol,CYP2D6,"No altered effect predicted bygenotype",-
Miscellaneous,Atazanavir,CYP3A5,"No altered effect predicted bygenotype",-
"",Cyclophosphamide,CYP2C19,"No altered effect predicted bygenotype",-
"",Proguanil,CYP2C19,"No altered effect predicted bygenotype",-
NSAIDs,Diclofenac,CYP2C9,"No altered effect predicted bygenotype",-
"",Indomethacin,CYP2C9,"No altered effect predicted bygenotype",-
"",Mefenamic Acid,CYP2C9,"No altered effect predicted bygenotype",-
Opioid Analgesics,Codeine,"CYP2D6OPRM1","Associated with increasedsensitivity to codeine",CPIC15
"",Hydrocodone,CYP2D6,"No altered effect predicted bygenotype",
"",Oxycodone,CYP2D6,"No altered effect predicted bygenotype",DPWG6
"",Tramadol,CYP2D6,"No altered effect predicted bygenotype",DPWG6
Psychostimulants,Dextroamphetamine,CYP2D6,"No altered effect predicted bygenotype",-
"",Lisdexamfetamine,CYP2D6,"No altered effect predicted bygenotype",-
Statins,Fluvastatin,"SLCO1B1CYP2C9","No altered effect predicted bygenotype",-
Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
